Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 2
1982 1
1983 2
1985 2
1986 4
1987 1
1988 1
1989 4
1990 16
1991 3
1992 8
1993 2
1994 7
1995 6
1996 4
1997 9
1998 6
1999 4
2000 5
2001 6
2002 10
2003 9
2004 9
2005 18
2006 12
2007 13
2008 12
2009 11
2010 12
2011 8
2012 4
2013 12
2014 10
2015 11
2016 6
2017 4
2018 14
2019 2
2020 9
2021 15
2022 8
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C, Pandit H, Nagy BA, Stellas D, Jensen SM, Bear J, Cam M, Valentin A, Fox BA, Felber BK, Pavlakis GN. Bergamaschi C, et al. Among authors: pavlakis gn. J Immunother Cancer. 2020 May;8(1):e000599. doi: 10.1136/jitc-2020-000599. J Immunother Cancer. 2020. PMID: 32461349 Free PMC article.
Heterodimeric IL-15 in Cancer Immunotherapy.
Bergamaschi C, Stravokefalou V, Stellas D, Karaliota S, Felber BK, Pavlakis GN. Bergamaschi C, et al. Among authors: pavlakis gn. Cancers (Basel). 2021 Feb 17;13(4):837. doi: 10.3390/cancers13040837. Cancers (Basel). 2021. PMID: 33671252 Free PMC article. Review.
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee JB, Ho Lee L, O'Keeffe JA, Lewis N, Pavlakis GN, Thompson JA. Leidner R, et al. Among authors: pavlakis gn. J Immunother Cancer. 2023 Oct;11(10):e007725. doi: 10.1136/jitc-2023-007725. J Immunother Cancer. 2023. PMID: 37907221 Free PMC article. Clinical Trial.
The benefits, costs and feasibility of a low incidence COVID-19 strategy.
Czypionka T, Iftekhar EN, Prainsack B, Priesemann V, Bauer S, Calero Valdez A, Cuschieri S, Glaab E, Grill E, Krutzinna J, Lionis C, Machado H, Martins C, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Skupin A, Schernhammer E, Szczurek E, Tsiodras S, Willeit P, Wilmes P. Czypionka T, et al. Among authors: pavlakis gn. Lancet Reg Health Eur. 2022 Feb;13:100294. doi: 10.1016/j.lanepe.2021.100294. Epub 2022 Jan 2. Lancet Reg Health Eur. 2022. PMID: 35005678 Free PMC article. Review.
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19.
Psaltopoulou T, Sergentanis TN, Pappa V, Politou M, Terpos E, Tsiodras S, Pavlakis GN, Dimopoulos MA. Psaltopoulou T, et al. Among authors: pavlakis gn. Hemasphere. 2020 May 21;4(3):e409. doi: 10.1097/HS9.0000000000000409. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647807 Free PMC article. Review.
Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates.
Dross S, Venkataraman R, Patel S, Huang ML, Bollard CM, Rosati M, Pavlakis GN, Felber BK, Bar KJ, Shaw GM, Jerome KR, Mullins JI, Kiem HP, Fuller DH, Peterson CW. Dross S, et al. Among authors: pavlakis gn. Front Immunol. 2023 May 3;14:1188018. doi: 10.3389/fimmu.2023.1188018. eCollection 2023. Front Immunol. 2023. PMID: 37207227 Free PMC article.
HIV DNA Vaccine: Stepwise Improvements Make a Difference.
Felber BK, Valentin A, Rosati M, Bergamaschi C, Pavlakis GN. Felber BK, et al. Among authors: pavlakis gn. Vaccines (Basel). 2014 May 14;2(2):354-79. doi: 10.3390/vaccines2020354. Vaccines (Basel). 2014. PMID: 26344623 Free PMC article. Review.
HIV vaccine: better to start together?
Felber BK, Pavlakis GN. Felber BK, et al. Among authors: pavlakis gn. Lancet HIV. 2019 Nov;6(11):e724-e725. doi: 10.1016/S2352-3018(19)30323-6. Epub 2019 Oct 7. Lancet HIV. 2019. PMID: 31601543 Free article. No abstract available.
291 results